SBP GROUP (01177): Tian Zhoushan retires as executive director.
China Biopharmaceuticals (01177) announced that Tian Zhoushan and Li Dakui have informed the company that they will respectively resign from their positions as executive director and independent non-executive director, effective from the end of the 2026 shareholders' annual meeting, and will not seek re-election.
SBP GROUP(01177) announced that Tian Zhoushan and Li Dakui have informed the company that they will resign from their positions as executive director and independent non-executive director, respectively, effective from the end of the 2026 annual general meeting, and will not seek re-election.
Related Articles
Orient (03958) first quarter net profit attributable to the parent company was 1.587 billion yuan, an increase of 10.55% year-on-year.
STERLING GP (01825) appoints Zhang Yuan as an independent non-executive director.
JINGCHENG MAC (00187) released its first-quarter financial results, with a net loss attributable to shareholders of approximately 32.21 million yuan, an increase of about 1.7 times year-on-year.
Orient (03958) first quarter net profit attributable to the parent company was 1.587 billion yuan, an increase of 10.55% year-on-year.
STERLING GP (01825) appoints Zhang Yuan as an independent non-executive director.
JINGCHENG MAC (00187) released its first-quarter financial results, with a net loss attributable to shareholders of approximately 32.21 million yuan, an increase of about 1.7 times year-on-year.
RECOMMEND
